Exact Mass: 876.4745

Exact Mass Matches: 876.4745

Found 7 metabolites which its exact mass value is equals to given mass value 876.4745, within given mass tolerance error 4.0E-5 dalton. Try search metabolite list with more accurate mass tolerance error 8.0E-6 dalton.

Spinorphin

(2S,3R)-2-{[(2S)-2-({[(2S)-1-[(2S)-2-{[(2S)-2-{[(2S)-2-{[(2S)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-3-methylbutylidene]amino}-1-hydroxy-3-methylbutylidene]amino}-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}-3-hydroxybutanoic acid

C45H64N8O10 (876.4745)


Spinorphin is an endogenous opioid heptapeptide that has the amino acid sequence Leu-Val-Val-Tyr-Pro-Trp-Thr (LVVYPWT). It has been observed to possess antinociceptive, antiallodynic and anti-inflammatory properties. The mechanism of action of spinorphin has not been fully elucidated but it has been found to act as an antagonist of the P2X3 receptor,[5] and as a weak partial agonist/antagonist of the FP1 receptor.

   

Neoviridogrisein I

Neoviridogrisein I

C45H64N8O10 (876.4745)


   
   
   

(2r,3s)-2-({[(3s,6r,9s,12s,15s)-3-benzyl-2,5,11,14-tetrahydroxy-6-(2-{2-[(hydroxymethylidene)amino]phenyl}-2-oxoethyl)-12-isopropyl-7-methyl-9-(2-methylpropyl)-8-oxo-1,4,7,10,13-pentaazacyclononadeca-1,4,10,13-tetraen-15-yl]-c-hydroxycarbonimidoyl}amino)-3-methylpentanoic acid

(2r,3s)-2-({[(3s,6r,9s,12s,15s)-3-benzyl-2,5,11,14-tetrahydroxy-6-(2-{2-[(hydroxymethylidene)amino]phenyl}-2-oxoethyl)-12-isopropyl-7-methyl-9-(2-methylpropyl)-8-oxo-1,4,7,10,13-pentaazacyclononadeca-1,4,10,13-tetraen-15-yl]-c-hydroxycarbonimidoyl}amino)-3-methylpentanoic acid

C45H64N8O10 (876.4745)


   

n-[(6s,9s,12s,15r,16s,19r,24ar)-9-ethyl-7,17-dihydroxy-2,5,11,15-tetramethyl-6-(3-methylbutan-2-yl)-19-(2-methylpropyl)-1,4,10,13,20-pentaoxo-12-phenyl-3h,6h,9h,12h,15h,16h,19h,22h,23h,24h,24ah-pyrrolo[2,1-o]1-oxa-4,7,10,13,16,19-hexaazacyclodocosan-16-yl]-3-hydroxypyridine-2-carboximidic acid

n-[(6s,9s,12s,15r,16s,19r,24ar)-9-ethyl-7,17-dihydroxy-2,5,11,15-tetramethyl-6-(3-methylbutan-2-yl)-19-(2-methylpropyl)-1,4,10,13,20-pentaoxo-12-phenyl-3h,6h,9h,12h,15h,16h,19h,22h,23h,24h,24ah-pyrrolo[2,1-o]1-oxa-4,7,10,13,16,19-hexaazacyclodocosan-16-yl]-3-hydroxypyridine-2-carboximidic acid

C45H64N8O10 (876.4745)


   

(2r,3r)-2-({[(3s,6r,9s,12s,15s)-3-benzyl-2,5,11,14-tetrahydroxy-6-(2-{2-[(hydroxymethylidene)amino]phenyl}-2-oxoethyl)-12-isopropyl-7-methyl-9-(2-methylpropyl)-8-oxo-1,4,7,10,13-pentaazacyclononadeca-1,4,10,13-tetraen-15-yl]-c-hydroxycarbonimidoyl}amino)-3-methylpentanoic acid

(2r,3r)-2-({[(3s,6r,9s,12s,15s)-3-benzyl-2,5,11,14-tetrahydroxy-6-(2-{2-[(hydroxymethylidene)amino]phenyl}-2-oxoethyl)-12-isopropyl-7-methyl-9-(2-methylpropyl)-8-oxo-1,4,7,10,13-pentaazacyclononadeca-1,4,10,13-tetraen-15-yl]-c-hydroxycarbonimidoyl}amino)-3-methylpentanoic acid

C45H64N8O10 (876.4745)